Back to Search
Start Over
Curcumin inhibits activation of Vgamma9Vdelta2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation.
- Source :
-
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2001 Sep 15; Vol. 167 (6), pp. 3454-62. - Publication Year :
- 2001
-
Abstract
- Curcumin, in addition to its role as a spice, has been used for centuries to treat inflammatory disorders. Although the mechanism of action remains unclear, it has been shown to inhibit the activation of NF-kappaB and AP-1, transcription factors required for induction of many proinflammatory mediators. Due to its low toxicity it is currently under consideration as a broad anti-inflammatory, anti-tumor cell agent. In this study we investigated whether curcumin inhibited the response of gammadelta T cells to protease-resistant phosphorylated derivatives found in the cell wall of many pathogens. The results showed that curcumin levels > or =30 microM profoundly inhibited isopentenyl pyrophosphate-induced release of the chemokines macrophage inflammatory protein-1alpha and -1beta and RANTES. Curcumin also blocked isopentenyl pyrophosphate-induced activation of NF-kappaB and AP-1. Commencing around 16 h, treatment with curcumin lead to the induction of cell death that could not be reversed by APC, IL-15, or IL-2. This cytotoxicity was associated with increased annexin V reactivity, nuclear expression of active caspase-3, cleavage of poly(ADP-ribose) polymerase, translocation of apoptosis-inducing factor to the nucleus, and morphological evidence of nuclear disintegration. However, curcumin led to only large scale DNA chromatolysis, as determined by a combination of TUNEL staining and pulse-field and agarose gel electrophoresis, suggesting a predominantly apoptosis-inducing factor-mediated cell death process. We conclude that gammadelta T cells activated by these ubiquitous Ags are highly sensitive to curcumin, and that this effect may contribute to the anti-inflammatory properties of this compound.
- Subjects :
- Adult
Amino Acid Chloromethyl Ketones pharmacology
Annexin A5 analysis
Antineoplastic Agents pharmacology
Caspase 3
Caspases metabolism
Chemokine CCL4
Chemokine CCL5 metabolism
Cycloheximide pharmacology
Cysteine Proteinase Inhibitors pharmacology
Electrophoresis, Agar Gel
Electrophoresis, Gel, Pulsed-Field
Enzyme Activation drug effects
Flow Cytometry
Humans
In Situ Nick-End Labeling
Interleukin-15 pharmacology
Interleukin-2 pharmacology
Macrophage Inflammatory Proteins metabolism
Molecular Weight
NF-kappa B antagonists & inhibitors
NF-kappa B metabolism
Organophosphorus Compounds antagonists & inhibitors
Organophosphorus Compounds pharmacology
Phosphorylation
Protein Synthesis Inhibitors pharmacology
T-Lymphocyte Subsets immunology
Transcription Factor AP-1 antagonists & inhibitors
Transcription Factor AP-1 metabolism
Tumor Necrosis Factor-alpha pharmacology
Anti-Inflammatory Agents, Non-Steroidal pharmacology
Antigens, Bacterial immunology
Apoptosis drug effects
Curcumin pharmacology
DNA Fragmentation drug effects
Hemiterpenes
Lymphocyte Activation drug effects
Organophosphorus Compounds immunology
Receptors, Antigen, T-Cell, gamma-delta analysis
T-Lymphocyte Subsets drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 0022-1767
- Volume :
- 167
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Journal of immunology (Baltimore, Md. : 1950)
- Publication Type :
- Academic Journal
- Accession number :
- 11544338
- Full Text :
- https://doi.org/10.4049/jimmunol.167.6.3454